A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC
Status:
Withdrawn
Trial end date:
2022-10-30
Target enrollment:
Participant gender:
Summary
This research study is studying an investigational drug, NC318, as a possible treatment for
subjects with advanced or metastatic non-small cell lung cancer in combination with
chemotherapy